Kymera Therapeutics KYMR
NASDAQ KYMR
$134.84 -1.80 (-1.32%)
At close: Nov 11, 2026 · 4:00 PM EST

Kymera Therapeutics (KYMR) Other Non-Current Liabilities (2020 - 2025)

Updated

Analysis

Kymera Therapeutics (KYMR) Other Non-Current Liabilities (2020 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Kymera Therapeutics 11.66 Bn 8.50 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 -9.41 Mn
Sep 30, 2023 8,000.00
Jun 30, 2023 230,000.00
Mar 31, 2023 237,000.00
Dec 31, 2022 248,000.00
Sep 30, 2022 256,000.00
Jun 30, 2022 264,000.00
Mar 31, 2022 273,000.00
Dec 31, 2021 66,000.00
Sep 30, 2021 76,000.00
Jun 30, 2021 84,000.00
Mar 31, 2021 92,000.00
Dec 31, 2020 100,000.00
API Access

Kymera Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=KYMR&period=max&api_key=YOUR_API_KEY